The American College of Surgeons (ACS) has established the American College of Surgeons Oncology Group (ACSOG) to conduct multicenter cooperative group trials designed to evaluate the role of surgical procedures in the treatment of patients with malignant solid tumors. The existence of a surgical clinical trial group is important to the oncological community because of the primary role of surgery in the treatment of the cancer patient. The trials will also evaluate the utility of selected new operations, technology, and instrumentation as they are introduced into clinical practice. Furthermore, the ACSOG will perform trials that are based on new basic science discoveries; specifically (a) the evaluation of new molecular markers in the diagnosis and treatment of the cancer patient and (b) the place of interventional therapy in patients demonstrated to have a genetic predisposition for cancer. Through its substantial education and communication programs the ACS will place great emphasis on the education of surgeons in clinical trial methodology and in the importance of their participation in the ACSOG clinical trials programs. The ACS is the largest organization of surgeons in the world with broad geographic membership distribution, including general surgeons and speciality surgeons in both academic medical centers and the private practice community. Furthermore, the Commission on Cancer (COC), of the ACS through the Approvals, Education, Cancer Liaison and National Cancer Database Programs has a large number of active professional staff and volunteers that serve and interact with the Cancer Programs and the practicing surgeons in the 1500 approved hospitals throughout the United States of America and Canada. The ACSOG is committed to performing clinical trials of patients with the most commonly occurring malignant solid tumors. This is evidenced b the concentration of the initial trials on patients with breast cancer, lung cancer and colorectal cancer. The performance of these trials will require a broad base of practicing surgeons in North America and this group of participants is well represented within the membership of the ACS.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
1U10CA076001-01
Application #
2441711
Study Section
Subcommittee G - Education (NCI)
Program Officer
Kaplan, Richard S
Project Start
1998-05-15
Project End
2000-04-30
Budget Start
1998-05-15
Budget End
1999-04-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
American College of Surgeons
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60611
Le-Petross, Huong T; McCall, Linda M; Hunt, Kelly K et al. (2018) Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol 210:669-676
Foster, Jared C; Le-Rademacher, Jennifer G; Feliciano, Josephine L et al. (2017) Comparative ""nocebo effects"" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort. Cancer 123:4193-4198
Brown, Paul D; Ballman, Karla V; Cerhan, Jane H et al. (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CECĀ·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049-1060
Churilla, Thomas M; Ballman, Karla V; Brown, Paul D et al. (2017) Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys 99:1173-1178
Ellis, Matthew J; Suman, Vera J; Hoog, Jeremy et al. (2017) Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol 35:1061-1069
Brown, Paul D; Jaeckle, Kurt; Ballman, Karla V et al. (2016) Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316:401-409
Haffty, Bruce G; McCall, Linda M; Ballman, Karla V et al. (2016) Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). Int J Radiat Oncol Biol Phys 94:493-502
Kent, Michael S; Mandrekar, Sumithra J; Landreneau, Rodney et al. (2016) Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance). Ann Thorac Surg 102:230-8
Boughey, Judy C; Ballman, Karla V; Le-Petross, Huong T et al. (2016) Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance) Ann Surg 263:802-7
Singh, Preet Paul; Shi, Qian; Foster, Nathan R et al. (2016) Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance). Oncologist 21:1509-1521

Showing the most recent 10 out of 68 publications